Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients

Condition:   Drug-induced HypotensionIntervention:   Sponsors:   Nicholaos C Bellos, MD;   GlaxoSmithKlineCompleted - verified December 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials